These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22733600)

  • 21. Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging.
    Sharma DK; Oma P; Pollo MJ; Sukumar M
    J Pharm Sci; 2010 Jun; 99(6):2628-42. PubMed ID: 20049937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the effect of syringe surfaces on protein formulations.
    Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
    J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction and analysis of aggregates in a liquid IgG1-antibody formulation.
    Mahler HC; Müller R; Friess W; Delille A; Matheus S
    Eur J Pharm Biopharm; 2005 Apr; 59(3):407-17. PubMed ID: 15760721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible NaCl-induced aggregation of a monoclonal antibody at low pH: Characterization of aggregates and factors affecting aggregation.
    Bickel F; Herold EM; Signes A; Romeijn S; Jiskoot W; Kiefer H
    Eur J Pharm Biopharm; 2016 Oct; 107():310-20. PubMed ID: 27449627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice.
    Kijanka G; Bee JS; Korman SA; Wu Y; Roskos LK; Schenerman MA; Slütter B; Jiskoot W
    J Pharm Sci; 2018 Nov; 107(11):2847-2859. PubMed ID: 30003898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods.
    Werk T; Volkin DB; Mahler HC
    Eur J Pharm Sci; 2014 Mar; 53():95-108. PubMed ID: 24370624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term stability of morphine hydrochloride in 0.9% NaCl infusion polyolefin bags after freeze-thaw treatment and in polypropylene syringes at 5 degrees C + 3 degrees C.
    Hecq JD; Godet M; Gillet P; Jamart J; Galanti L
    Int J Pharm Compd; 2014; 18(1):78-82. PubMed ID: 24881344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.
    Li L; Kirkitadze M; Bhandal K; Roque C; Yang E; Carpick B; Rahman N
    Curr Pharm Biotechnol; 2017 Nov; 18(8):638-647. PubMed ID: 28914197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure, stability, and mobility of a lyophilized IgG1 monoclonal antibody as determined using second-derivative infrared spectroscopy.
    Murphy BM; Zhang N; Payne RW; Davis JM; Abdul-Fattah AM; Matsuura JE; Herman AC; Manning MC
    J Pharm Sci; 2012 Jan; 101(1):81-91. PubMed ID: 21918984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No Touching! Abrasion of Adsorbed Protein Is the Root Cause of Subvisible Particle Formation During Stirring.
    Sediq AS; van Duijvenvoorde RB; Jiskoot W; Nejadnik MR
    J Pharm Sci; 2016 Feb; 105(2):519-529. PubMed ID: 26869415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevant shaking stress conditions for antibody preformulation development.
    Eppler A; Weigandt M; Hanefeld A; Bunjes H
    Eur J Pharm Biopharm; 2010 Feb; 74(2):139-47. PubMed ID: 19922795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Transportation of IV Bags Containing Protein Formulations Via Hospital Pneumatic Tube System: Particle Characterization by Multiple Methods.
    Linkuvienė V; Ross EL; Crawford L; Weiser SE; Man D; Kay S; Kolhe P; Carpenter JF
    J Pharm Sci; 2022 Apr; 111(4):1024-1039. PubMed ID: 35093336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface activity of a monoclonal antibody.
    Mahler HC; Senner F; Maeder K; Mueller R
    J Pharm Sci; 2009 Dec; 98(12):4525-33. PubMed ID: 19655376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polysorbate 20 Degradation in Biopharmaceutical Formulations: Quantification of Free Fatty Acids, Characterization of Particulates, and Insights into the Degradation Mechanism.
    Tomlinson A; Demeule B; Lin B; Yadav S
    Mol Pharm; 2015 Nov; 12(11):3805-15. PubMed ID: 26419339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
    Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
    J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vented spikes improve delivery from intravenous bags with no air headspace.
    Galush WJ; Horst TA
    J Pharm Sci; 2015 Jul; 104(7):2397-400. PubMed ID: 25953689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin.
    Serno T; Carpenter JF; Randolph TW; Winter G
    J Pharm Sci; 2010 Mar; 99(3):1193-206. PubMed ID: 19774651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.